Study of Carotid Atherosclerosis in Non-alcoholic Fatty Liver Disease Patients and Its Correlation With Serum Transaminases
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Non-alcoholic fatty liver disease (NAFLD) is linked to increased carotid intima-media thickness (CIMT), a marker of atherosclerosis. This suggests NAFLD patients need cardiovascular risk assessment, especially those over 50.
Area Of Science
- Hepatology
- Cardiology
- Metabolic Syndrome
Background
- Non-alcoholic fatty liver disease (NAFLD) is increasingly linked to metabolic syndrome and cardiovascular disease (CVD).
- Carotid intima-media thickness (CIMT) is a key indicator of subclinical atherosclerosis and a predictor of CVD risk.
Purpose Of The Study
- To assess carotid atherosclerosis in NAFLD patients using CIMT.
- To explore correlations between NAFLD, CIMT, and metabolic/biochemical parameters, including liver enzymes (ALT, AST) and triglycerides.
Main Methods
- A hospital-based case-control study involving 50 NAFLD patients and 50 healthy controls.
- Methods included clinical assessment, ultrasound for hepatic steatosis and CIMT, liver function tests, and lipid profiles.
Main Results
- NAFLD patients exhibited significantly increased CIMT, particularly those over 50 (p<0.001).
- CIMT correlated positively with fatty liver severity and alanine aminotransferase (ALT) levels (p<0.039), but not aspartate aminotransferase (AST).
- NAFLD was associated with obesity, diabetes, dyslipidemia, and elevated triglycerides.
Conclusions
- NAFLD is associated with early vascular changes (elevated CIMT) and metabolic dysfunction.
- ALT levels and triglycerides are linked to subclinical atherosclerosis in NAFLD.
- Routine cardiovascular risk stratification is recommended for NAFLD patients, especially those over 50.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
Technological Integration: EUS is a sophisticated integration of optical endoscopy and ultrasonography. The endoscope visualizes the mucosal surface directly, while the ultrasound component penetrates deeper to visualize organs and structures beyond the gastrointestinal wall.
Image Formation: The ultrasound...
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...